Fidaxomicin
Fidaxomicin is a semisynthetic macrolide antibiotic used to treat Clostridium difficile-associated diarrhea in adults. Fidaxomicin has minimal systemic absorption and has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent, acute liver injury.
| Catalog Number | T6194 |
| Alternative Name(s) | Tiacumicin B , OPT-80 , Clostomicin B1 , PAR-101 |
| Research Area | Cell Cycle/Checkpoint|||DNA Damage/DNA Repair|||Apoptosis|||Microbiology/Virology |
| Molecular Formula | C52H74Cl2O18 |
| CAS# | 873857-62-6 |
| Purity | 99.23% |
| SMILES | CC[C@H]1\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)c3c(O)c(Cl)c(O)c(Cl)c3CC)[C@H](O)[C@@H]2OC)\C(=O)O[C@@H](C\C=C(C)\C=C(C)\[C@@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O)[C@@H](C)O |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Fidaxomicin |
| Additional Information | https://www.targetmol.com/datasheet/T6194 |